Resident since 2019

Acrus BioMed
Medical technology, equipment and biopharma

Validity period
20 years
Acrus BioMed Company is engaged in the development and production of biomedical cell products (BMCP). One of the founders of the new industry, unites the most qualified specialists. First–line products-BMCP for the treatment of long-term non-healing wounds, ulcers and extensive burns, allowing to restore the skin in a short time and without scarring.

Acrus BioMed cooperates with leading research institutions-developers, in pipe-line companies - new BMCP for the treatment of various socially significant diseases. On the universal equipment of the company, it is possible to contract the production of other BMCP of various composition and purpose, as well as their components. The registration process is currently underway and the products will be available for use in 2021.

Наш сайт использует файлы cookie для хранения данных.
Продолжая использовать сайт, вы даёте согласие на работу с этими файлами.